Amid media reports that Chetan and Nitin Sandesara, both directors of Gujarat based pharma company Sterling Biotech and wanted in an over Rs 5,000 crore bank fraud case may have fled the country, the Central Bureau of Investigation (CBI) on Monday said that it has "no information" about their whereabouts.
A senior CBI official said that it has no information on the whereabouts of Chetan and Nitin Sandesara.
The agency's official's remark came soon after media reports said that Chetan and Nitin had fled to Nigeria with their families.
The CBI had booked Sterling Biotech, its directors Chetan Jayantilal Sandesara, Dipti Chetan Sandesara, Rajbhushan Omprakash Dixit, Nitin Jayantilal Sandesara and Vilas Joshi, chartered accountant Hemant Hathi, former Director of Andhra Bank Anup Prakash Garg and some unidentified persons in connection with the alleged bank fraud in October 2017.
According to the CBI FIR, Sterling Biotech had taken over Rs 5,000 crore loans from a consortium of banks led by Andhra Bank, which had turned into non-performing assets. The total pending dues of the group companies were Rs 5,383 crore as on December 31, 2016.
The Enforcement Directorate (ED) initiated a money laundering probe into the case taking cognizance of the CBI FIR.
On January 13, the ED arrested Garg. The agency also arrested a Delhi-based businessman Gagan Dhawan in connection with the case in November last year. The ED also attached properties worth Rs 4,703 crore.
The ED in a statement said that the loans to the tune of Rs 5,000 crore was disbursed by the various banks during the years 2004-2012.
It also said that the look out circulars against the accused were opened in August 2017.
During the course of investigation, three persons were arrested, one of them named Gagan Dhawan who was close to the "power centre" when the loans were sanctioned.
The ED also said that it was finding more properties.
--IANS
aks/ahm/bg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
